Examining associations between prescription stimulant misuse frequency and misuse characteristics by race/ethnicity

被引:1
|
作者
Mendez, Jocelyne [1 ]
Yomogida, Kyle [1 ]
Figueroa, Wilma [1 ]
Roldan, Kate Diaz [1 ]
Bavarian, Niloofar [1 ]
机构
[1] Calif State Univ Long Beach, Long Beach, CA 90840 USA
关键词
Prescription stimulant misuse; frequency; misuse characteristics; substance use; theory; of triadic influence; COLLEGE-STUDENTS; ILLICIT USE; NONMEDICAL USE; ROUTES; PREVALENCE; DIVERSION; MEDICATION; MOTIVES; ABUSE;
D O I
10.1080/15332640.2021.1952128
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction The misuse use of prescription stimulants (MPS) among college students is a pressing public health concern. Past research suggests there is variation in MPS frequency by race/ethnicity. According to the Theory of Triadic Influence, a health behavior can increase in frequency based on experiences and characteristics of the behavior. Thus, our aim was to examine the association between experiences and characteristics of MPS with MPS frequency, by race/ethnicity. Methods A probability sample of students attending two California universities completed a paper-based, psychometrically validated, instrument. Students who reported engaging in MPS in their lifetime were also asked questions about frequency, cost per pill, administration routes, sources, and experience with the drug. We used regression analyses to address our research questions, and conducted analyses by racial/ethnic group (i.e. for students identifying as Asian, Latinx, and White). Results MPS frequency did not vary by race/ethnicity. The influence of characteristics of misuse on frequency varied by race/ethnicity. Additionally, frequency of experiencing the desired outcome was significantly associated with increased MPS frequency across all three racial/ethnic groups. Conclusions Characteristics of misuse are important to consider when screening for misuse and potential dependence. Particular attention should be given to these characteristics by race/ethnicity. Implications for future research are discussed.
引用
收藏
页码:402 / 416
页数:15
相关论文
共 50 条
  • [1] Prescription stimulant misuse avoidance self-efficacy: Correlates and moderation by race/ethnicity
    Figueroa, Wilma
    Yomogida, Kyle
    Mendez, Jocelyne
    Bavarian, Niloofar
    JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE, 2020, 19 (03) : 476 - 489
  • [2] THE ASSOCIATION BETWEEN PRESCRIPTION STIMULANT USE AND PRESCRIPTION DRUG MISUSE
    Dunn, T. J.
    Korgaonkar, S.
    Ramachandran, S.
    VALUE IN HEALTH, 2018, 21 : S189 - S189
  • [3] Prescription Stimulant Misuse in a Military Population
    Kennedy, Jennifer N.
    Bebarta, Vikhyat S.
    Varney, Shawn M.
    Zarzabal, Lee Ann
    Ganem, Victoria J.
    MILITARY MEDICINE, 2015, 180 (03) : 191 - 194
  • [4] Prescription Stimulant Misuse Among Nursing Students
    Magnotti, Sebastian
    Beatty, Avery
    Bickford, Erek
    Channell, Isabella
    Weyandt, Lisa
    JOURNAL OF ADDICTIONS NURSING, 2023, 34 (03) : 216 - 223
  • [5] Examining the Associations Between Substance Misuse and Suicide Bereavement
    Feigelman, William
    Cerel, Julie
    Gutin, Nina
    Mcintosh, John L.
    Gorman, Bernard S.
    Bottomley, Jamison S.
    Edwards, Alice
    OMEGA-JOURNAL OF DEATH AND DYING, 2024,
  • [7] Confirming the Prevalence, Characteristics, and Utility of Ecological Theory in Explaining Prescription Stimulant Misuse
    Bavarian, Niloofar
    Sumstine, Stephanie
    Cruz, Sheena
    Mendez, Jocelyne
    Schroeder, Cassandra
    Takeda, Summer
    JOURNAL OF DRUG ISSUES, 2018, 48 (01) : 118 - 133
  • [8] Predictors of Prescription Stimulant Misuse in US College Graduates
    Holt, Laura J.
    McCarthy, Megan D.
    SUBSTANCE USE & MISUSE, 2020, 55 (04) : 644 - 657
  • [9] Stimulant Prescription Cautions: Addressing Misuse, Diversion and Malingering
    Rabiner, David L.
    CURRENT PSYCHIATRY REPORTS, 2013, 15 (07)
  • [10] OVERCOMING DEFENSIVE RESPONDING IN THE ESTIMATION OF PRESCRIPTION STIMULANT MISUSE
    Ramachandran, Sujith
    Bentley, John
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2023, 19 (07): : E1090 - E1090